Drug Resistance, Rather than Low Tenofovir Levels in Blood or Urine, Is Associated with Tenofovir, Emtricitabine, and Efavirenz Failure in Resource-Limited Settings-Reference-Cited by-同舟云学术

Drug Resistance, Rather than Low Tenofovir Levels in Blood or Urine, Is Associated with Tenofovir, Emtricitabine, and Efavirenz Failure in Resource-Limited Settings

Published:2021-12-29 Issue: Volume: Page:
ISSN:0889-2229
Container-title:AIDS Research and Human Retroviruses
language:en
Short-container-title:AIDS Research and Human Retroviruses

Author:

Jennings Lauren¹,Kellermann Tracy²,Spinelli Matthew³^ORCID,Nkantsu Zukiswa¹,Cogill Dolphina¹,van Schalkwyk Marije⁴,Decloedt Eric²,van Zyl Gert⁵⁶,Orrell Catherine¹,Gandhi Monica³^ORCID

Affiliation:

1. Desmond Tutu HIV Centre, Institute of Infectious Disease and Molecular Medicine and Department of Medicine, University of Cape Town, South Africa.

2. Division of Clinical Pharmacology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.

3. Division of HIV, Infectious Diseases, and Global Medicine at UCSF/San Francisco General Hospital, San Francisco, California, USA.

4. Division of Infectious Diseases, Department of Medicine, Stellenbosch University, Cape Town, South Africa.

5. Division of Medical Virology, Stellenbosch University, Faculty of Medicine and Health Sciences, Cape Town, South Africa.

6. National Health Laboratory Service, Tygerberg Business Unit, Cape Town, South Africa.

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Virology,Immunology

Link

https://www.liebertpub.com/doi/pdf/10.1089/aid.2021.0135

Reference38 articles.

1. A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa

2. Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection

3. Incomplete ART adherence is associated with higher inflammation in individuals who achieved virologic suppression in the START study

4. Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incentivizing adherence to pre-exposure prophylaxis for HIV prevention: a randomized pilot trial among male sex workers in Mexico;The European Journal of Health Economics;2024-07-13

2. HIV at a crossroads in Pakistan;The Lancet HIV;2024-05

3. Low-cost urine tenofovir assay to triage dolutegravir resistance testing;The Lancet HIV;2024-05

4. Point-of-care urine tenofovir monitoring of adherence to drive interventions for HIV treatment and prevention;Expert Review of Molecular Diagnostics;2024-02-14

5. Proposal of pharmacophore model for HIV reverse transcriptase inhibitors: Combined mutational effect analysis, molecular dynamics, molecular docking and pharmacophore modeling study;International Journal of Immunopathology and Pharmacology;2024-01